Skip to search formSkip to main contentSkip to account menu

Hyperphosphatemia (disorder)

Known as: Hyperphosphatemias, Hyperphosphatemia, Hyperphosphatemia [Disease/Finding] 
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
National Institutes of Health

Related topics

Related topics

20 relations
Disorder of electrolytesHYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROMEHyperphosphaturiaIn Blood

Narrower (1)

Hyperostosis-hyperphosphatemia syndrome

Broader (1)

Phosphorus Metabolism Disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Review
2011
Review
2011
The tumor lysis syndrome.
The tumor lysis syndrome is the most common disease-related emergency in children and adults with hematologic cancers. This… 
Review
2010
Review
2010
Calcific uremic arteriolopathy
Calcific uremic arteriolopathy (CUA)/calciphylaxis is an important cause of morbidity and mortality in patients with chronic… 
Highly Cited
2009
Highly Cited
2009
Vascular calcification: the killer of patients with chronic kidney disease.
Cardiovascular complications are the leading cause of death in patients with chronic kidney disease (CKD). Vascular calcification… 
Highly Cited
2008
Highly Cited
2008
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
BACKGROUND Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of urinary excretion of phosphate and… 
Highly Cited
2005
Highly Cited
2005
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Hyperphosphatemia, calcitriol deficiency, and secondary hyperparathyroidism (SHPT) are common complications of chronic kidney… 
Highly Cited
2005
Highly Cited
2005
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Background— Higher levels of serum phosphate are associated with adverse cardiovascular outcomes, especially in the setting of… 
Highly Cited
2001
Highly Cited
2001
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.
Hyperphosphatemia is highly prevalent among patients with end-stage renal disease (ESRD) and is associated with increased… 
Highly Cited
2000
Highly Cited
2000
Phosphate regulation of vascular smooth muscle cell calcification.
Vascular calcification is a common finding in atherosclerosis and a serious problem in diabetic and uremic patients. Because of… 
Review
2000
Review
2000
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)